Missing diversity in brain tumor trials.

Birra TahaGraham Winston Umberto TosiBenjamin HartleyCaitlin HoffmanNadia DahmaneChristopher E MasonJeffrey P Greenfield

Published in: Neuro-oncology advances (2020)

Despite increasing representation in the American population, minorities are underrepresented in brain tumor trials. In addition, despite numerous legal requirements and ethical mandates, published results including race-based information are remarkably absent from 70% of brain tumor trials.

Keyphrases

healthcare
randomized controlled trial
health information